| |
|
|
|
PLx Pharma Inc.  
|
|
5.41 -0.39 (-0.07%) |
08-22 11:45 |
|
Open: |
5.5 |
Pre close: |
5.8 |
Target:
|
7.07
|
|
High: |
5.65 |
Low: |
5.41 |
Resistance:
|
6.05
6.57
|
|
Volume: |
101 |
Market Cap: |
49M |
Support:
|
5.23
4.35
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
5.70
 |
MACD |
MACD(12,26):
|
-0.12 |
|
MA(20): |
5.79 |
Signal(12,26,9): |
-0.11 |
|
MA(100): |
5.69 |
Stochastic Oscillator |
%K(14,3):
|
25.81 |
|
MA(250): |
4.78  |
%D(3): |
34.16 |
|
Average Volume(K) |
3-Month: |
924
|
52-Week |
High:
|
7.41 |
|
10-Days: |
322 |
Low: |
1.00 |
|
RSI |
RSI(14):
|
43.16 |
Change(%): |
62.7 |
|
Financials, Statistics and Valuation |
|
EPS |
-3.870 |
Return on Equity (ttm) |
-566.3 |
Shares Out. (M) |
8.87 |
|
EPS Est. Current Year |
-1.610 |
Return on Assets (ttm) |
-31.1 |
Shares Float (M) |
7.36 |
|
EPS Est. Next Year |
-1.820 |
PEG Ratio |
-0.06 |
% Held by Insiders |
1.90 |
|
EPS Est. Next Quarter |
-0.460 |
Qtrly Rev. Growth |
9.2 |
% Held by Institutions |
24.33 |
|
Forward EPS |
-1.350 |
Gross Profit (p.s.) |
0.085 |
Shares Short (K) |
165 |
|
Book Value (p.s.) |
-1.500 |
EBITDA (p.s.) |
-1.340 |
P/E |
-1.40 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-3.61 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-9.55 |
P/S |
399889152.00 |
|
Operating Margin |
-1203.86 |
Levered Free Cash Flow
(M) |
-5.41 |
P/CF |
-5.02 |
|
|
|
|
|
|
